Compare TMDX & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | COLD |
|---|---|---|
| Founded | 1998 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.1B |
| IPO Year | 2019 | 2018 |
| Metric | TMDX | COLD |
|---|---|---|
| Price | $136.66 | $10.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $133.00 | $15.93 |
| AVG Volume (30 Days) | 835.5K | ★ 7.4M |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 8.56% |
| EPS Growth | ★ 170.70 | N/A |
| EPS | ★ 2.54 | N/A |
| Revenue | $566,354,000.00 | ★ $2,607,407,000.00 |
| Revenue This Year | $38.84 | N/A |
| Revenue Next Year | $20.43 | N/A |
| P/E Ratio | $53.83 | ★ N/A |
| Revenue Growth | ★ 41.20 | N/A |
| 52 Week Low | $55.00 | $10.10 |
| 52 Week High | $156.00 | $23.62 |
| Indicator | TMDX | COLD |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 40.25 |
| Support Level | $133.50 | $10.62 |
| Resistance Level | $156.00 | $11.33 |
| Average True Range (ATR) | 8.50 | 0.40 |
| MACD | 0.41 | 0.13 |
| Stochastic Oscillator | 55.98 | 65.85 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.